Efficacy Data from US Clinical Efficacy Trials with Sumatriptan Injection in Pat

Fast

Printer-friendly versionSend to friendPDF version
Title Image: 
Efficacy Data from US Clinical Efficacy Trials with Sumatriptan Injection in Pat

In clinical studies, relief started within 10 minutes for some patients, with most achieving relief within 2 hours.
SUMAVEL DosePro also relieves sensitivity to light, sound, nausea and vomiting associated with migraine attacks.

Efficacy Data from US Clinical Efficacy Trials with Sumatriptan Injection in Patients with Migraine
 

Sumavel DosePro Efficacy Information Survery#1

Sumavel DosePro Efficacy Information Survery#2

The efficacy of subcutaneous sumatriptan injection is unaffected by whether or not migraine is associated with aura, duration of attack, gender or age of the patient, or concomitant use of common migraine prophylactic drugs (e.g., beta-blockers).